DFDA

Erythromycin

Treatment for Diphtheria

Typical Dosage: 250-500 mg orally QID

Effectiveness
95%
Safety Score
70%
Clinical Trials
50
Participants
15K

Comparative Safety Scale(Higher is safer)

Cyanide☠ī¸
Meth💀
CigarettesđŸšŦ
Chemoâ˜ĸī¸
AlcoholđŸē
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
70
DangerousModerateSafe
Treatment Details
Dosage Range
250-500 mg orally QID
Time to Effect
24-48 hours
Treatment Duration
14 days
Evidence Quality
HIGH
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$50
Monitoring:$100
Side Effect Mgmt:$100
Total Annual:$250
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
QALYs Gained
0.3
Outcome-Based Costs
Cost per Responder
$263
Cost per Remission
$263
Prescription Access Economics
Physician Visit Cost
$125/year
Time Cost
$35/year
Travel + wait time
Insurance Admin Cost
$20/year
Prior auth, claims
Rx Price
$50/year
Potential OTC Price
$25/year
Estimated if OTC available
Early Treatment Benefit
+0.05 QALYs
From faster OTC access
Risk Assessment
Misuse Risk
MODERATE
Missed Diagnosis Risk
HIGH
Erythromycin Outcomes

for Diphtheria

Efficacy Outcomes
Overall Effectiveness
+95%
Response Rate
+95%
Remission Rate
+95%
Common Side Effects
Gastrointestinal upset
+15%
QT prolongation
+1%
Allergic reactions (rash)
+0.5%

Sources:

nih.gov
cdc.gov
oregon.gov

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov